Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung

Respiratory Medicine

Volumn 97, Issue 11, 2003, Pages 1237-1242

  Lee, J H ^a   Chang, J H ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Bronchodilator; Chronic airflow obstruction; Spirometry; Tuberculosis

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FENOTEROL;

ADULT; AGE DISTRIBUTION; AGED; AIRWAY RESISTANCE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; KOREA; LUNG FUNCTION TEST; LUNG INJURY; LUNG TUBERCULOSIS; MALE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SPIROMETRY; VITAL CAPACITY; WHEEZING;

EID: 0242351156     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(03)00255-5     Document Type: Article

References (22)

1. Bobrowitz ID, Rodescu D, Marcus H, Abeles H. The destroyed tuberculous lung. Scand J Respir Dis 1974;55:82-8.
2. Mannino DM. COPD, epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121:S121-6.
3. Senior RM, Anthonisen NR. Chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:S139-47.
4. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis. Review of the worldwide situation and the WHO/ IUATLD Global Surveillance Project. Clin Infect Dis 1997;24:S121-30.
5. Ministry of Health and Welfare Korean Nation Tuberculosis Association. Report on the seventh tuberculosis prevalence survey in Korea, Seoul; 1996.
6. American Thoracic Society. Standards for the diagnosis, care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-120.
7. McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest 2001;119:1190-209.
8. Quanjer PhH, Tammeling GF, Cotes JE, Pedersen OF, Reslin F, Yernault JC. Lung volumes and forced ventilatory flows. Official Statement of the European Respiratory Society. Eur Respir J 1993;6:S5-40.
9. World Health Organization. The GOLD global strategy for the management and prevention of COPD. Available at: http://www.goldcopd.com. Accessed March 16, 2001.
10. Chhabra SK, Vijayan VK, Gupta R, De S. Expression of bronchodilator response: comparison of four indices. Resp Med 2002;96:611-4.
11. Palmer PES. Pulmonary tuberculosis; usual and unusual radiographic presentations. Sem Roentgenol 1979;14:28-67.
12. Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971;103:625-40.
13. Ashour M, Pandya L, Mezraqji A, et al. Unilateral post-tuberculous lung destruction; the left bronchus syndrome. Thorax 1990;45:210-2.
14. Wouters EFM. Nutrition and metabolism in COPD. Chest 2000;117:S274-80.
15. Last RJ. Anatomy, regional and applied. London: Churchill Livingstone; 1978.
16. Williams PL, Warwich R. Gray's anatomy. 36th ed. revised. London: Churchill Livingstone; 1980.
17. Groth S, Mortensen J, Lange P, Munch EP, Sorensen PG, Rossing N. Imaging of airways of bronchoscintigraphy for the study of mucociliary clearance. Thorax 1988;43:360-5.
18. Skoogh BE. Lung mechanics in pulmonary tuberculosis. I. Static lung volumes. Scand J Respir Dis 1973;54:148-56.
19. Koyama H, Nishimura K, Mio T, Izumi T. Emphysematous changes assessed by selective alveolobronchography and bronchodilator response in chronic airway obstruction. Lung 1994;172:103-12.
20. Im JG, Itoh H, Lee KS, Han MC. CT-pathology correlation of pulmonary tuberculosis. Crit Rev Diagn Imaging 1995; 36:227-85.
21. Ferguson GT. Recommendations for the management of COPD. Chest 2000;117:S23-8.
22. O'Donnell DE. Assessment of bronchodilator efficacy in symptomatic COPD. Chest 2000;117:S42-7.